The global market for Oxycodone Hydrochloride Injection was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Oxycodone Hydrochloride Injection is a strong opioid analgesic used to relieve moderate to severe pain. Its main ingredient is oxycodone hydrochloride, a semi-synthetic opioid receptor agonist with a strong analgesic effect.

North American market for Oxycodone Hydrochloride Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Oxycodone Hydrochloride Injection is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Oxycodone Hydrochloride Injection in Hospital is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Oxycodone Hydrochloride Injection include Sumitomo Pharma America, Inc., NAPP PHARMACEUTICALS LIMITED, Teva Takeda Yakuhin Ltd., LTL Pharma Co., Ltd., Mylan Pharmaceuticals, Organon LLC, Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Teva Pharmaceutical Industries, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Oxycodone Hydrochloride Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oxycodone Hydrochloride Injection.

The Oxycodone Hydrochloride Injection market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oxycodone Hydrochloride Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oxycodone Hydrochloride Injection companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oxycodone Hydrochloride Injection Market Report

Report Metric	Details
Report Name	Oxycodone Hydrochloride Injection Market
Segment by Type	2ml:20mg 1ml:10mg
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Sumitomo Pharma America, Inc., NAPP PHARMACEUTICALS LIMITED, Teva Takeda Yakuhin Ltd., LTL Pharma Co., Ltd., Mylan Pharmaceuticals, Organon LLC, Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Teva Pharmaceutical Industries
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oxycodone Hydrochloride Injection company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Oxycodone Hydrochloride Injection Market report?

Ans: The main players in the Oxycodone Hydrochloride Injection Market are Sumitomo Pharma America, Inc., NAPP PHARMACEUTICALS LIMITED, Teva Takeda Yakuhin Ltd., LTL Pharma Co., Ltd., Mylan Pharmaceuticals, Organon LLC, Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Teva Pharmaceutical Industries

What are the Application segmentation covered in the Oxycodone Hydrochloride Injection Market report?

Ans: The Applications covered in the Oxycodone Hydrochloride Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Oxycodone Hydrochloride Injection Market report?

Ans: The Types covered in the Oxycodone Hydrochloride Injection Market report are 2ml:20mg, 1ml:10mg

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oxycodone Hydrochloride Injection Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 2ml:20mg

1.2.3 1ml:10mg

1.3 Market by Application

1.3.1 Global Oxycodone Hydrochloride Injection Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oxycodone Hydrochloride Injection Market Perspective (2020-2031)

2.2 Global Oxycodone Hydrochloride Injection Growth Trends by Region

2.2.1 Global Oxycodone Hydrochloride Injection Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Oxycodone Hydrochloride Injection Historic Market Size by Region (2020-2025)

2.2.3 Oxycodone Hydrochloride Injection Forecasted Market Size by Region (2026-2031)

2.3 Oxycodone Hydrochloride Injection Market Dynamics

2.3.1 Oxycodone Hydrochloride Injection Industry Trends

2.3.2 Oxycodone Hydrochloride Injection Market Drivers

2.3.3 Oxycodone Hydrochloride Injection Market Challenges

2.3.4 Oxycodone Hydrochloride Injection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oxycodone Hydrochloride Injection Players by Revenue

3.1.1 Global Top Oxycodone Hydrochloride Injection Players by Revenue (2020-2025)

3.1.2 Global Oxycodone Hydrochloride Injection Revenue Market Share by Players (2020-2025)

3.2 Global Oxycodone Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Oxycodone Hydrochloride Injection Revenue

3.4 Global Oxycodone Hydrochloride Injection Market Concentration Ratio

3.4.1 Global Oxycodone Hydrochloride Injection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oxycodone Hydrochloride Injection Revenue in 2024

3.5 Global Key Players of Oxycodone Hydrochloride Injection Head office and Area Served

3.6 Global Key Players of Oxycodone Hydrochloride Injection, Product and Application

3.7 Global Key Players of Oxycodone Hydrochloride Injection, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Oxycodone Hydrochloride Injection Breakdown Data by Type

4.1 Global Oxycodone Hydrochloride Injection Historic Market Size by Type (2020-2025)

4.2 Global Oxycodone Hydrochloride Injection Forecasted Market Size by Type (2026-2031)

5 Oxycodone Hydrochloride Injection Breakdown Data by Application

5.1 Global Oxycodone Hydrochloride Injection Historic Market Size by Application (2020-2025)

5.2 Global Oxycodone Hydrochloride Injection Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Oxycodone Hydrochloride Injection Market Size (2020-2031)

6.2 North America Oxycodone Hydrochloride Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Oxycodone Hydrochloride Injection Market Size by Country (2020-2025)

6.4 North America Oxycodone Hydrochloride Injection Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oxycodone Hydrochloride Injection Market Size (2020-2031)

7.2 Europe Oxycodone Hydrochloride Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Oxycodone Hydrochloride Injection Market Size by Country (2020-2025)

7.4 Europe Oxycodone Hydrochloride Injection Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oxycodone Hydrochloride Injection Market Size (2020-2031)

8.2 Asia-Pacific Oxycodone Hydrochloride Injection Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Oxycodone Hydrochloride Injection Market Size by Region (2020-2025)

8.4 Asia-Pacific Oxycodone Hydrochloride Injection Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oxycodone Hydrochloride Injection Market Size (2020-2031)

9.2 Latin America Oxycodone Hydrochloride Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Oxycodone Hydrochloride Injection Market Size by Country (2020-2025)

9.4 Latin America Oxycodone Hydrochloride Injection Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oxycodone Hydrochloride Injection Market Size (2020-2031)

10.2 Middle East & Africa Oxycodone Hydrochloride Injection Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country (2020-2025)

10.4 Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Sumitomo Pharma America, Inc.

11.1.1 Sumitomo Pharma America, Inc. Company Details

11.1.2 Sumitomo Pharma America, Inc. Business Overview

11.1.3 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Introduction

11.1.4 Sumitomo Pharma America, Inc. Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.1.5 Sumitomo Pharma America, Inc. Recent Development

11.2 NAPP PHARMACEUTICALS LIMITED

11.2.1 NAPP PHARMACEUTICALS LIMITED Company Details

11.2.2 NAPP PHARMACEUTICALS LIMITED Business Overview

11.2.3 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Introduction

11.2.4 NAPP PHARMACEUTICALS LIMITED Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.2.5 NAPP PHARMACEUTICALS LIMITED Recent Development

11.3 Teva Takeda Yakuhin Ltd.

11.3.1 Teva Takeda Yakuhin Ltd. Company Details

11.3.2 Teva Takeda Yakuhin Ltd. Business Overview

11.3.3 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Introduction

11.3.4 Teva Takeda Yakuhin Ltd. Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.3.5 Teva Takeda Yakuhin Ltd. Recent Development

11.4 LTL Pharma Co., Ltd.

11.4.1 LTL Pharma Co., Ltd. Company Details

11.4.2 LTL Pharma Co., Ltd. Business Overview

11.4.3 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Introduction

11.4.4 LTL Pharma Co., Ltd. Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.4.5 LTL Pharma Co., Ltd. Recent Development

11.5 Mylan Pharmaceuticals

11.5.1 Mylan Pharmaceuticals Company Details

11.5.2 Mylan Pharmaceuticals Business Overview

11.5.3 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Introduction

11.5.4 Mylan Pharmaceuticals Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.5.5 Mylan Pharmaceuticals Recent Development

11.6 Organon LLC

11.6.1 Organon LLC Company Details

11.6.2 Organon LLC Business Overview

11.6.3 Organon LLC Oxycodone Hydrochloride Injection Introduction

11.6.4 Organon LLC Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.6.5 Organon LLC Recent Development

11.7 Santen Pharmaceutical Co.,Ltd.

11.7.1 Santen Pharmaceutical Co.,Ltd. Company Details

11.7.2 Santen Pharmaceutical Co.,Ltd. Business Overview

11.7.3 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Introduction

11.7.4 Santen Pharmaceutical Co.,Ltd. Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.7.5 Santen Pharmaceutical Co.,Ltd. Recent Development

11.8 Hengrui Medicine

11.8.1 Hengrui Medicine Company Details

11.8.2 Hengrui Medicine Business Overview

11.8.3 Hengrui Medicine Oxycodone Hydrochloride Injection Introduction

11.8.4 Hengrui Medicine Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.8.5 Hengrui Medicine Recent Development

11.9 Teva Pharmaceutical Industries

11.9.1 Teva Pharmaceutical Industries Company Details

11.9.2 Teva Pharmaceutical Industries Business Overview

11.9.3 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Introduction

11.9.4 Teva Pharmaceutical Industries Revenue in Oxycodone Hydrochloride Injection Business (2020-2025)

11.9.5 Teva Pharmaceutical Industries Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Sumitomo Pharma America, Inc.

NAPP PHARMACEUTICALS LIMITED

Teva Takeda Yakuhin Ltd.

LTL Pharma Co., Ltd.

Mylan Pharmaceuticals

Organon

Santen Pharmaceutical Co., Ltd.

Hengrui Medicine

Teva Pharmaceutical Industries

List of Tables

Table 1. Global Oxycodone Hydrochloride Injection Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of 2ml:20mg

Table 3. Key Players of 1ml:10mg

Table 4. Global Oxycodone Hydrochloride Injection Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Oxycodone Hydrochloride Injection Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Oxycodone Hydrochloride Injection Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Oxycodone Hydrochloride Injection Market Share by Region (2020-2025)

Table 8. Global Oxycodone Hydrochloride Injection Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Oxycodone Hydrochloride Injection Market Share by Region (2026-2031)

Table 10. Oxycodone Hydrochloride Injection Market Trends

Table 11. Oxycodone Hydrochloride Injection Market Drivers

Table 12. Oxycodone Hydrochloride Injection Market Challenges

Table 13. Oxycodone Hydrochloride Injection Market Restraints

Table 14. Global Oxycodone Hydrochloride Injection Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Oxycodone Hydrochloride Injection Market Share by Players (2020-2025)

Table 16. Global Top Oxycodone Hydrochloride Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxycodone Hydrochloride Injection as of 2024)

Table 17. Ranking of Global Top Oxycodone Hydrochloride Injection Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Oxycodone Hydrochloride Injection Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Oxycodone Hydrochloride Injection, Headquarters and Area Served

Table 20. Global Key Players of Oxycodone Hydrochloride Injection, Product and Application

Table 21. Global Key Players of Oxycodone Hydrochloride Injection, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Oxycodone Hydrochloride Injection Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Oxycodone Hydrochloride Injection Revenue Market Share by Type (2020-2025)

Table 25. Global Oxycodone Hydrochloride Injection Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Oxycodone Hydrochloride Injection Revenue Market Share by Type (2026-2031)

Table 27. Global Oxycodone Hydrochloride Injection Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Oxycodone Hydrochloride Injection Revenue Market Share by Application (2020-2025)

Table 29. Global Oxycodone Hydrochloride Injection Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Oxycodone Hydrochloride Injection Revenue Market Share by Application (2026-2031)

Table 31. North America Oxycodone Hydrochloride Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Oxycodone Hydrochloride Injection Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Oxycodone Hydrochloride Injection Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Oxycodone Hydrochloride Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Oxycodone Hydrochloride Injection Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Oxycodone Hydrochloride Injection Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Oxycodone Hydrochloride Injection Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Oxycodone Hydrochloride Injection Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Oxycodone Hydrochloride Injection Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Oxycodone Hydrochloride Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Oxycodone Hydrochloride Injection Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Oxycodone Hydrochloride Injection Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Oxycodone Hydrochloride Injection Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country (2026-2031) & (US$ Million)

Table 46. Sumitomo Pharma America, Inc. Company Details

Table 47. Sumitomo Pharma America, Inc. Business Overview

Table 48. Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Product

Table 49. Sumitomo Pharma America, Inc. Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 50. Sumitomo Pharma America, Inc. Recent Development

Table 51. NAPP PHARMACEUTICALS LIMITED Company Details

Table 52. NAPP PHARMACEUTICALS LIMITED Business Overview

Table 53. NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Product

Table 54. NAPP PHARMACEUTICALS LIMITED Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 55. NAPP PHARMACEUTICALS LIMITED Recent Development

Table 56. Teva Takeda Yakuhin Ltd. Company Details

Table 57. Teva Takeda Yakuhin Ltd. Business Overview

Table 58. Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Product

Table 59. Teva Takeda Yakuhin Ltd. Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 60. Teva Takeda Yakuhin Ltd. Recent Development

Table 61. LTL Pharma Co., Ltd. Company Details

Table 62. LTL Pharma Co., Ltd. Business Overview

Table 63. LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Product

Table 64. LTL Pharma Co., Ltd. Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 65. LTL Pharma Co., Ltd. Recent Development

Table 66. Mylan Pharmaceuticals Company Details

Table 67. Mylan Pharmaceuticals Business Overview

Table 68. Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Product

Table 69. Mylan Pharmaceuticals Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 70. Mylan Pharmaceuticals Recent Development

Table 71. Organon LLC Company Details

Table 72. Organon LLC Business Overview

Table 73. Organon LLC Oxycodone Hydrochloride Injection Product

Table 74. Organon LLC Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 75. Organon LLC Recent Development

Table 76. Santen Pharmaceutical Co.,Ltd. Company Details

Table 77. Santen Pharmaceutical Co.,Ltd. Business Overview

Table 78. Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Product

Table 79. Santen Pharmaceutical Co.,Ltd. Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 80. Santen Pharmaceutical Co.,Ltd. Recent Development

Table 81. Hengrui Medicine Company Details

Table 82. Hengrui Medicine Business Overview

Table 83. Hengrui Medicine Oxycodone Hydrochloride Injection Product

Table 84. Hengrui Medicine Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 85. Hengrui Medicine Recent Development

Table 86. Teva Pharmaceutical Industries Company Details

Table 87. Teva Pharmaceutical Industries Business Overview

Table 88. Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Product

Table 89. Teva Pharmaceutical Industries Revenue in Oxycodone Hydrochloride Injection Business (2020-2025) & (US$ Million)

Table 90. Teva Pharmaceutical Industries Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Oxycodone Hydrochloride Injection Picture

Figure 2. Global Oxycodone Hydrochloride Injection Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oxycodone Hydrochloride Injection Market Share by Type: 2024 VS 2031

Figure 4. 2ml:20mg Features

Figure 5. 1ml:10mg Features

Figure 6. Global Oxycodone Hydrochloride Injection Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Oxycodone Hydrochloride Injection Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Oxycodone Hydrochloride Injection Report Years Considered

Figure 12. Global Oxycodone Hydrochloride Injection Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Oxycodone Hydrochloride Injection Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Oxycodone Hydrochloride Injection Market Share by Region: 2024 VS 2031

Figure 15. Global Oxycodone Hydrochloride Injection Market Share by Players in 2024

Figure 16. Global Top Oxycodone Hydrochloride Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oxycodone Hydrochloride Injection as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Oxycodone Hydrochloride Injection Revenue in 2024

Figure 18. North America Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Oxycodone Hydrochloride Injection Market Share by Country (2020-2031)

Figure 20. United States Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Oxycodone Hydrochloride Injection Market Share by Country (2020-2031)

Figure 24. Germany Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Oxycodone Hydrochloride Injection Market Share by Region (2020-2031)

Figure 32. China Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Oxycodone Hydrochloride Injection Market Share by Country (2020-2031)

Figure 40. Mexico Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Oxycodone Hydrochloride Injection Market Share by Country (2020-2031)

Figure 44. Turkey Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Oxycodone Hydrochloride Injection Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Sumitomo Pharma America, Inc. Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 48. NAPP PHARMACEUTICALS LIMITED Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 49. Teva Takeda Yakuhin Ltd. Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 50. LTL Pharma Co., Ltd. Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 51. Mylan Pharmaceuticals Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 52. Organon LLC Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 53. Santen Pharmaceutical Co.,Ltd. Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 54. Hengrui Medicine Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 55. Teva Pharmaceutical Industries Revenue Growth Rate in Oxycodone Hydrochloride Injection Business (2020-2025)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions